Reports Q4 revenue $199.2M, consensus $193.29M.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ITCI:
- Intra-Cellular downgraded to Hold from Buy at Canaccord
- Johnson & Johnson says positioned for 5%-7% growth through 2030 and beyond
- Reviva Pharmaceuticals price target lowered to $11 from $14 at H.C. Wainwright
- Intra-Cellular downgraded to Sector Perform from Outperform at RBC Capital
- Sector Spotlight: Big Pharma will push to pause Medicare drug price negotiations
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue